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Summary
Objective: To study the role of nitric oxide (NO) in cartilage destruction in murine models of arthritis and osteoarthritis.
Methods: Joint inflammation was induced in the knee joint by intraarticular injection of Zymosan. Osteoarthritis was induced by local injection
of bacterial collagenase, causing joint instability. The effect of NO deficiency was studied by comparing the effects in normal mice and mice
with genetically disrupted NOS2 (inducible NO synthase). Impact on articular cartilage was evaluated by histology and measurement of
chondrocyte 35S-proteoglycan synthesis.
Results: NOS2 deficiency prevented chondrocyte proteoglycan synthesis inhibition in the arthritic cartilage and restored normal responsive-
ness to IGF-1. Net cartilage proteoglycan depletion was markedly reduced in the absence of NOS2, although inflammation was hardly
affected. Osteoarthritic joint pathology was also significantly reduced, including diminished cartilage lesions and osteophyte formation.
Conclusion: NO plays a major role in cartilage damage in both arthritic and osteoarthritic conditions.
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Chronic joint inflammation is characterized by cartilage
destruction, which consists of inhibited synthesis of matrix
as well as enhanced breakdown of matrix. It is found that
IL-1 plays a major part in this destruction, predominantly
through its key role in the process of proteoglycan
synthesis inhibition.1 Although IL-1 can be involved in
proteoglycan breakdown, substantial overkill by other
mediators may occur. Although inhibition of IL-1 does not
always prevent early proteoglycan loss in acute inflam-
mation, it reduces late, erosive changes.2 Apart from
the impact of IL-1, disturbed chondrocyte matrix
synthesis may result from a disturbance in proper IGF-1
signaling.3
IL-1 is a potent stimulant of nitric oxide (NO). Cells in the
synovial tissue and articular chondrocytes can produce
considerable amounts of NO and the production in arthritic
conditions can be linked to constitutive NO-synthase as
well as inducible NO-synthase (iNOS or NOS2). Studies
with inhibitors of NO have suggested that NO plays a major
role in IL-1 effects and joint pathology. However, the inhibi-
tors used are not fully selective and results may be flawed
by side effects. In the present study we made use of NOS2
deficient mice4 to study its role in arthritis and osteoarthritis.
Since immune driven inflammation can be markedly
impaired in NOS2 deficient mice, we confined the study to
the model of nonimmune inflammation, induced with
Zymosan. For comparison, we also studied the impact of
deficiency of the cytokines TNF, IL-1b, and IL-6. Moreover,
the OA model was studied in NOS2 and IL-1b knock-out
mice.413Materials and methods
ARTHRITIS MODEL
A dose of 180 ug Zymosan was injected into the right
knee of the various mouse strains. At various days there-
after, patellar cartilage was isolated and cultured for 3
hours in the presence of 35S-sulfate, or first incubated for
24 hours in a medium with or without IGF-1 (0.5 ug/ml),
before 35S-sulfate pulse labeling. At the end of the exper-
iment whole knee joints were isolated, processed for his-
tology and stained with Safranin O to depict proteoglycan
loss in the cartilage.OSTEOARTHRITIS MODEL
1 U bacterial collagenase was injected into the knee joint
at days 1 and 4. This caused minor joint inflammation and
no measurable cartilage damage in the acute stage. At day
42 the mice were killed and knee joints processed for
histology. Cartilage lesions were evaluated in the tibial-
femoral area and osteophytes were scored at the margins
of tibia and femur and at insertion sites of ligaments.Results and discussionAddress correspondence to: Wim B. van den Berg, Department
of Rheumatology, University Hospital Nijmegen, 6500 HB
Nijmegen, The Netherlands.PROTEOGLYCAN SYNTHESIS
Joint inflammation induced with Zymosan does result in
marked inhibition of proteoglycan synthesis in the articular
cartilage. This was evident at day 1 after induction of
inflammation and synthesis remained suppressed as long
as there was active inflammation. When joint inflammation
was induced in NOS2 deficient mice, proteoglycan syn-
thesis was not reduced. In fact, the synthetic activity was
even above normal at day 2 (Fig. 1a). For comparison,
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that TNF-a or IL-6 deficiency had no major influence on this
parameter. Moreover, IL-1b deficiency did not reduce this
suppression. Preliminary studies with additional treatment
of the latter mice with anti-IL-1a antibodies made it clear
that both types of IL-1 have to be suppressed, before full
restoration of PG synthesis can be accomplished. It further
demonstrates that IL-1a is a prominent isoform in early
arthritis. The negative findings in the TNF- a and IL-6
deficient mice underline two key points: TNF- a is not a
dominant inducer of IL-1 in this model, although such a role
has been claimed in rheumatoid arthritis; moreover, IL-6 is
not a secundary cytokine, mediating the IL-1 effects. In fact,
studies at later stages of the Zymosan model made it clear
that net proteoglycan loss is enhanced in IL-6 deficient
5mice, implying a protective role of IL-6 in destruction.IGF-RESPONSIVENESS
Apart from direct ex-vivo proteoglycan synthesis
measurements in the arthritic cartilage, we also analysed
the IGF responsiveness in a subsequent 24 h cultureperiod of the isolated patellar cartilage specimens. Pre-
vious studies showed that arthritic chondrocytes are non-
responsive to the main anabolic stimulus IGF-1.3 Now we
show that NO is a crucial element in this phenomenon.
Figure 1b displays that cartilage from wild type, arthritic
mice only shows 20% stimulation of its PG synthesis in the
presence of IGF-1, as compared to a 100% stimulation in
normal cartilage. This IGF-1 stimulation pattern is not
significantly different in arthritic cartilage obtained from
TNF-Æ, IL-1â or IL-6 knock-outs, whereas the IGF-1
response was nearly normal in the NOS2 deficient cartilage
specimens.INFLAMMATION
Acute joint inflammation was not significantly reduced in
the IL-1b and NOS2 deficient mice,6 marked reduction in
joint swelling was seen in the TNF- a knock-out, whereas
inflammation was also reduced in the IL-6 deficient
animals.Fig. 1. A: Proteoglycan synthesis in patellar cartilage measured at
day 2 after induction of Zymosan arthritis, by 3 h pulse labeling
with 35S-sulfate in vitro. Synthesis is expressed as a percentage of
the activity in normal cartilage. B: The above cartilage specimens
are cultured for 24 h in the presence or absence of IGF-1, followed
by 3 h 35S-sulfate labeling. Values are expressed as a percentage
of IGF stimulation compared to the respective controls in the
absence of IGF-1. The stimulation found in normal cartilage is
posed at 100%.OA PATHOLOGY IN NOS2 DEFICIENT MICE
Osteoarthritis was induced in normal and NOS2 deficient
mice by local injection of bacterial collagenase into the
knee joint. Cartilage lesions develop after a few weeks in
the weight bearing sites in the tibial plateau, in line with the
biomechanical nature of the model.8 In fact, collagenase
damages the ligament structures of the joint and provokes
major instability. Osteophytes occur before cartilage
lesions. Figure 2 shows the comparison of the pathology in
normal and NOS2 deficient mice at day 42. It is clear that
both the degree of cartilage damage as well as the extent
of osteophyte formation is reduced in the absence of
inducible NO. Recent studies in the canine ACL model
revealed similar suppressive effects with NO inhibitors.9
Moreover, blocking of IL-1 also provided reduction of
lesions in the canine model.10 Our preliminary observations
in the IL-1b deficient mice suggested that cartilage damage
was reduced when minor instability was induced, but when
the model was made more severe the protective effect in
the absence of IL-1â was lost. This might suggest that theCARTILAGE PROTEOGLYCAN DEPLETION
This was measured by loss of Safranin O staining of
histologic joint sections. At day 7 cartilage proteoglycan
depletion was more than 50% reduced in the NOS2
deficient mice as compared to the loss in wild type mice.
Intriguingly, progressive loss of proteoglycan was seen at
days 14 and 21, both in the wild type and in the NOS2
deficient mice, in spite of the fully normalized synthetic
activity in the latter, and the relative differences remained
similar. This implies that the early differences were due to
the normalization of synthesis, but that proteolytic break-
down is on ongoing process in the joint inflammation,
apparently independent of NO. This is in line with earlier in
vitro studies which revealed that IL-1 mediated inhibition of
cartilage proteoglycan synthesis was NO dependent,7 but
that IL-1 mediated cartilage degradation was similar or
even enhanced in the presence of NO inhibitors.
For comparison, late histology in IL-1â and TNF deficient
mice shows almost complete protection from PG depletion
in the IL-1â −/− mice, whereas there was still considerable
PG depletion in the absence of TNF-Æ.
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IL-1. In fact, proteoglycan synthesis is enhanced in stead
of inhibited in early OA, not compatible with a dominant role
of IL-1 in that stage. In late stages of OA, chondrocyte
proteoglycan synthesis does diminish and a more dominant
role of IL-1 seems likely. There is no doubt that NO
production is enhanced in late stage human OA and IL-17
appears a probable inducer.11
Apart from cartilage lesions, we also analyzed the osteo-
phytes. These were 50% reduced as well in the NOS2
deficient mice (Fig. 2). The mechanism of osteophyte
formation is not fully understood, but it is clear that TGF-â
can induce osteophytes which resemble the OA osteo-
phytes, making this growth factor a likely candidate.12,13
We recently injected or overexpressed TGF-â in the knee
joint of NOS2 deficient mice, but could not find reduced
osteophyte formation in these animals. This implies that the
TGF-â effect is not NO dependent, leaving reduced TGF-â
production in NO deficient mice as a potential mechanism.Fig. 2. OA cartilage lesions in the tibial-femural area and osteo-
phyte formation at the joint margins at day 42 after induction of
collagenase instability OA. Values are the mean of groups of 15
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